DRI officials seize 119.4 kg of Alprazolam worth Rs. 23.88 crore

New Delhi:  The officers of Directorate of Revenue Intelligence from Hyderabad, Visakhapatnam, Vijayawada and Kakinada executed a swift and well-coordinated operation resulting in seizure of 119.4 kg Alprazolam in lumpy form, valued at approximately Rs. 23.88 crore in the illicit market, along with 87.8 kg in-process material. The DRI officials also apprehended eight persons involved in illegal manufacturing and distribution of Alprazolam, including the master-mind, chemists, financiers and the buyers at the same place.

After developing a specific intelligence that a few persons were clandestinely manufacturing ‘Alprazolam’ — a psychotropic substance under the NDPS Act, 1985 — at a facility in Atchutapuram, Anakapalli District, Andhra Pradesh, the DRI officials meticulously planned the operation to arrest the entire set of persons involved in manufacturing and distribution of Alprazolam.

Additionally, 3,600 litres in liquid form and 311.6 kg in solid form of illegally procured raw materials, equipment (two reactors, one centrifuge and one drier) used for manufacturing Alprazolam and few incriminating documents were seized to aid further investigation.

All the eight accused persons were arrested and remanded to judicial custody. It is noteworthy that most of the arrested individuals have prior involvement in cases related to the clandestine manufacture of narcotic drugs and psychotropic substances and other criminal activities (murder, cyber-crimes and economic offences).

Initial interrogation revealed that these individuals conspired to undertake this illegal activity, having formed their network during their time in jail, underscoring the deep-rooted and organized nature of the syndicate. The said Alprazolam was intended for transport to Telangana for adulterating Toddy.

Further investigation in the case is in progress.

Related Posts

Cough Syrup Took Betul Boy’s Voice

Nagpur:  For nearly two months, a mother from Betul fought a lonely battle as her 3.5-year-old son Harsh battled renal failure and swelling in the brain at AIIMS Nagpur, caused…

Comply with global practices by Jan 1 or shut shop: CDSCO to pharma manufacturers after cough syrup deaths

The CDSCO has made clear there will be no further opportunities for extensions, meaning any units that remain non-compliant by the deadline must suspend operations until requirements are met. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Cough Syrup Took Betul Boy’s Voice

Cough Syrup Took Betul Boy’s Voice

Comply with global practices by Jan 1 or shut shop: CDSCO to pharma manufacturers after cough syrup deaths

Comply with global practices by Jan 1 or shut shop: CDSCO to pharma manufacturers after cough syrup deaths

Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India

Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India

Seven state-of the-art common infra facilities to come up at Ujjain Medical Devices Park

Seven state-of the-art common infra facilities to come up at Ujjain Medical Devices Park

Kala Amb firm linked to drug racket sealed by NCB

Kala Amb firm linked to drug racket sealed by NCB

Expired medicines: 2 hospitals barred from PM-JAY

Expired medicines: 2 hospitals barred from PM-JAY